Significance of B7-H1 Overexpression in Kidney Cancer

Pantuck, 2001, The changing natural history of renal cell carcinoma, J Urol, 166, 1611, 10.1016/S0022-5347(05)65640-6 Leibovich, 2003, Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials, Cancer, 97, 1663, 10.1002/cncr.11234 Figlin, 1997, Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor, J Urol, 158, 740, 10.1016/S0022-5347(01)64304-0 Yang, 2003, Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer, J Clin Oncol, 21, 3127, 10.1200/JCO.2003.02.122 Flanigan, 2001, Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer, N Engl J Med, 345, 1655, 10.1056/NEJMoa003013 Childs, 2000, Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation, N Engl J Med, 343, 750, 10.1056/NEJM200009143431101 Couillard, 1993, Surgery of renal cell carcinoma, Urol Clin N Am, 20, 263, 10.1016/S0094-0143(21)00485-7 Bromwich, 2003, The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer, Br J Cancer, 89, 1906, 10.1038/sj.bjc.6601400 Nakano, 2001, Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity, Cancer Res, 61, 5132 Uzzo, 1999, Mechanisms of apoptosis in T cells from patients with renal cell carcinoma, Clin Cancer Res, 5, 1219 Kudo, 2003, Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells, Cancer Res, 63, 1676 Rayman, 2004, Effect of renal cell carcinomas on the development of type 1 T-cell responses, Clin Cancer Res, 10, 6360S, 10.1158/1078-0432.CCR-050011 Lahn, 1999, Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma, Eur Urol, 35, 70, 10.1159/000019821 Alexander, 1993, T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors, Cancer Res, 53, 1380 Chen, 2004, Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity, Nat Rev Immunol, 4, 336, 10.1038/nri1349 Dong, 1999, B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, Nat Med, 5, 1365, 10.1038/70932 Dong, 2002, Tumor-associated B7-H1 promotes Tcell apoptosis: a potential mechanism of immune evasion, Nat Med, 8, 793, 10.1038/nm0902-1039c Brown, 2003, Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production, J Immunol, 170, 1257, 10.4049/jimmunol.170.3.1257 Konishi, 2004, B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression, Clin Cancer Res, 10, 5094, 10.1158/1078-0432.CCR-04-0428 Wintterle, 2003, Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis, Cancer Res, 63, 7462 Ohigashi, 2005, Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer, Clin Cancer Res, 11, 2947, 10.1158/1078-0432.CCR-04-1469 Curiel, 2003, Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity, Nat Med, 9, 562, 10.1038/nm863 Thompson, 2004, Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target, Proc Natl Acad Sci U S A, 101, 17174, 10.1073/pnas.0406351101 Iwai, 2002, Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade, Proc Natl Acad Sci U S A, 99, 12293, 10.1073/pnas.192461099 Hirano, 2005, Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity, Cancer Res, 65, 1089 Thompson, 2005, Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma, Cancer, 104, 2084, 10.1002/cncr.21470 Thompson, 2005, B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma, Urol, 66, 10, 10.1016/j.urology.2005.06.010 Thompson, 2006, Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up, Cancer Res, 66, 3381, 10.1158/0008-5472.CAN-05-4303 Weinberg, 2000, Engagement of the OX-40 receptor in vivo enhances antitumor immunity, J Immunol, 164, 2160, 10.4049/jimmunol.164.4.2160 Cheuk, 2004, Role of 4-1BB:4-1BB ligand in cancer immunotherapy, Cancer Gene Ther, 11, 215, 10.1038/sj.cgt.7700670 Chambers, 2001, CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy, Annu Rev Immunol, 19, 565, 10.1146/annurev.immunol.19.1.565 Dong, 2003, B7-H1 pathway and its role in the evasion of tumor immunity, J Mol Med, 81, 281, 10.1007/s00109-003-0430-2 Dong, 2004, B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes, Immunity, 20, 327, 10.1016/S1074-7613(04)00050-0 Ficarra, 2006, External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma, J Urol, 175, 1235, 10.1016/S0022-5347(05)00684-1 Frank, 2002, An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score, J Urol, 168, 2395, 10.1016/S0022-5347(05)64153-5 Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4, Immunity, 3, 541, 10.1016/1074-7613(95)90125-6 Phan, 2003, Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma, Proc Natl Acad Sci U S A, 100, 8372, 10.1073/pnas.1533209100 Rosenberg, 2001, Progress in human tumour immunology and immunotherapy, Nature, 411, 380, 10.1038/35077246 Campbell, 2006, Prognostic factors for renal cell carcinoma: integrating laboratory and molecular factors, J Urol, 175, 813, 10.1016/S0022-5347(05)00764-0